Exploring the relationship between metabolism and immune microenvironment in breast cancer bone metastasis based on metabolic pathways
Fig 5
Construction of a metabolism-related risk model.
(A) Kaplan-Meier curves of OS differences between high- and low-risk groups. (B) Differences in ImmuneScore, StromalScore, and TumorPurity between high- and low-risk groups. (C) Differences in the abundance of 28 immune cell types between high- and low-risk groups. (D) AUC values at 1, 3, and 5 years in the timeROC curve. (F) Drug sensitivity analysis between high- and low-risk groups. *p < 0.05, **p < 0.01, ***p < 0.001.